Related references
Note: Only part of the references are listed.Association of the Novel Serologic Anti-glycan Antibodies Anti-laminarin and Anti-chitin with Complicated Crohn's Disease Behavior
Florian Rieder et al.
INFLAMMATORY BOWEL DISEASES (2010)
Serum Anti-Glycan Antibodies Predict Complicated Crohn's Disease Behavior: A Cohort Study
Florian Rieder et al.
INFLAMMATORY BOWEL DISEASES (2010)
Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype
Cynthia H. Seow et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort
Maria Papp et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Increased Immune Reactivity Predicts Aggressive Complicating Crohn's Disease in Children
Marla C. Dubinsky et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease
Daniele Simondi et al.
INFLAMMATORY BOWEL DISEASES (2008)
Determination of serologic and genetic markers aid in the determination of the clinical course and severity of patients with IBD
Shane M. Devlin et al.
INFLAMMATORY BOWEL DISEASES (2008)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange et al.
JOURNAL OF CROHNS & COLITIS (2008)
New serological markers in inflammatory bowel disease are associated with complicated disease behaviour
Marc Ferrante et al.
GUT (2007)
Antibodies to 12 predict clinical response to fecal diversion in Crohn's disease
Jacob Spivak et al.
INFLAMMATORY BOWEL DISEASES (2006)
Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease
Iris Dotan et al.
GASTROENTEROLOGY (2006)
European evidence based consensus on the diagnosis and management of Crohn's disease:: definitions and diagnosis
EF Stange et al.
GUT (2006)
Anti-glycan antibodies as biomarkers for diagnosis and prognosis
N. Dotan et al.
LUPUS (2006)
Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease
E Israeli et al.
GUT (2005)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
WS Mow et al.
GASTROENTEROLOGY (2004)
Utility of Serum Antibodies in Determining Clinical Course in Pediatric Crohn's Disease
Barbara Desir et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype
IDR Arnott et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens
CJ Landers et al.
GASTROENTEROLOGY (2002)
Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases
J Bartunková et al.
CLINICAL IMMUNOLOGY (2002)
Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease
E Louis et al.
GUT (2001)
Decreased anti-Saccharomyces cerevisiae antibody titer by mesalazine in patients with Crohn's disease
N Oshitani et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2000)
Share Paper
